temozolomide has been researched along with Adrenocortical Carcinoma in 3 studies
Adrenocortical Carcinoma: A malignant neoplasm of the ADRENAL CORTEX. Adrenocortical carcinomas are unencapsulated anaplastic (ANAPLASIA) masses sometimes exceeding 20 cm or 200 g. They are more likely to be functional than nonfunctional, and produce ADRENAL CORTEX HORMONES that may result in hypercortisolism (CUSHING SYNDROME); HYPERALDOSTERONISM; and/or VIRILISM.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Temozolomide therapy was well tolerated and most toxicities were limited to grade G1-2 according to WHO criteria." | 5.51 | Activity and safety of temozolomide in advanced adrenocortical carcinoma patients. ( Badalamenti, G; Basile, V; Berruti, A; Cerri, S; Cosentini, D; Dalla Volta, A; Ferrari, VD; Grisanti, S; Incorvaia, L; Laganà , M; Luppi, G; Musso, E; Perotti, P; Rapa, I; Russo, A; Sigala, S; Spallanzani, A; Terzolo, M; Volante, M, 2019) |
| "Treatment of patients with adrenocortical carcinomas (ACC) with mitotane and/or chemotherapy is often associated with toxicity and poor tumor response." | 3.83 | Inhibition of Human Adrenocortical Cancer Cell Growth by Temozolomide in Vitro and the Role of the MGMT Gene. ( Creemers, SG; de Herder, WW; Feelders, RA; Franssen, GJ; Hofland, LJ; Korpershoek, E; van den Dungen, ES; van Kemenade, FJ; van Koetsveld, PM, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Cosentini, D | 2 |
| Badalamenti, G | 1 |
| Grisanti, S | 2 |
| Basile, V | 1 |
| Rapa, I | 1 |
| Cerri, S | 1 |
| Spallanzani, A | 1 |
| Perotti, P | 1 |
| Musso, E | 1 |
| Laganà , M | 2 |
| Ferrari, VD | 2 |
| Luppi, G | 1 |
| Dalla Volta, A | 1 |
| Incorvaia, L | 1 |
| Sigala, S | 2 |
| Russo, A | 1 |
| Volante, M | 1 |
| Terzolo, M | 1 |
| Berruti, A | 2 |
| Turla, A | 1 |
| Carminati, O | 1 |
| Rosti, G | 1 |
| Creemers, SG | 1 |
| van Koetsveld, PM | 1 |
| van den Dungen, ES | 1 |
| Korpershoek, E | 1 |
| van Kemenade, FJ | 1 |
| Franssen, GJ | 1 |
| de Herder, WW | 1 |
| Feelders, RA | 1 |
| Hofland, LJ | 1 |
3 other studies available for temozolomide and Adrenocortical Carcinoma
| Article | Year |
|---|---|
Activity and safety of temozolomide in advanced adrenocortical carcinoma patients.
Topics: Adrenocortical Carcinoma; Adult; Aged; DNA Modification Methylases; DNA Repair Enzymes; Humans; Midd | 2019 |
Case Report: Exceptional Response to Second Line Temozolomide Therapy in a Patient With Metastatic Adrenocortical Carcinoma.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Adult; Antineoplastic Combined Chemotherapy Prot | 2021 |
Inhibition of Human Adrenocortical Cancer Cell Growth by Temozolomide in Vitro and the Role of the MGMT Gene.
Topics: Adolescent; Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Adult; Aged; Aged, 80 and over; Anti | 2016 |